STAB
Statera Biopharma, Inc. Common Stock
STAB
STAB
Delisted
STAB was delisted on the 11th of January, 2023.
29 hedge funds and large institutions have $200K invested in Statera Biopharma, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$55.2K | |
| 2 | +$4.22K | |
| 3 | +$3.59K | |
| 4 |
HF
HRT Financial
New York
|
+$3.11K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.87K |
Top Sellers
| 1 | -$80.5K | |
| 2 | -$13K | |
| 3 | -$13K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$12.2K |
| 5 |
Two Sigma Investments
New York
|
-$5K |